RESEARCH-USE BIOSIMILAR ANTIBODY
Rontalizumab
Monoclonal antibody · IgG2
Rontalizumab is a humanized IgG1 monoclonal antibody targets IFN-α. Rontalizumab can be used for the research of systemic lupus erythematosus[1].
TARGETIFNA1
YMonoclonal antibody
CATALOGSC-BS-212
CATALOG NUMBERSC-BS-212
MOLECULAR WEIGHTApprox. 146.18 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Rontalizumab is a humanized IgG1 monoclonal antibody targets IFN-α. Rontalizumab can be used for the research of systemic lupus erythematosus[1].
Rontalizumab is a recombinant research-use antibody directed against IFNA1.